2Fagien S.Botox for the treatment of dynamic and hyperkinetic facial lines and furrows:adjunctive use in facial aesthetic surgery[J].Mast Reconstr Surg,1999,103:7012713.
3Fagien S,Brandt FS.Primary and adjunctive use of botulinum toxin type A(Botox)in facial aesthetic surgery:beyond the glabella[J].Clin Plast Surg,2001,28:127-148.
4Chen MA,Davidson TM.Scar management:prevention and treatment strategies[J].Current Opinion in Otolaryngology & Head & Neck Surgery,2005,13(4):242-247.
5Mustoe TA,Cooter RD,Gold,MH,et al.Intemationalclinicalrecommendations on scar management[J].Plast Reconstr Surg,2002,110(2):560-571.
6Gassner,Holger G,Sherris David A,et al.Treatment of facialwounds with bomlinum toxin A improves cosmetic outcome inprimates[J].Plast Reconstr Surg,2000,105(6):1948-1953.
7Atkinson JA,McKenna KT,Barnett AG,et al.Randomized controlledtrial to determine the efficacy of paper tape in preventinghypertrophic scar formation in surgical incisions that traverse langer'sskin tension lines[J].Plast Reconstr Surg,2005,116(6):1648-1656.
8Carruther J,Carruther A. Treatment of glabellar frown lines with c botulinum- a exotoxin [J].Dermatol Surg Oncol, 1992,18:17.
9Flyrm TC. Adwances in the use of botulinum neurotoxins in facial esthetics[J]. J Cosmet Dermatol,2012,11(1):42-50.
10Gill HS,Kraft SP. Long-term efficacy of botulinum a toxin for blepharospasm and hemifacial spasm [J].Can J Neurol Sci, 2010,37(5):631-636.
